Circadian Variation of Serum Uric Acid in Patients with Coronary Artery Diseases

Circadian Variation of Serum Uric Acid in Patients with Coronary Artery Diseases - Circadian Variation of Serum Uric Acid in Patients with Coronary Artery Diseases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021624

Enrollment

Registered

2016-04-01

Start date

2016-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

blood and urine examination study duration: 4 days

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients who are scheduled to undergo percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: ?hyperuricemia or gout under treatment ?under treatmet that affects serum uric acid ?under treatment for sleep apnea syndrome ?chronic obstructive pulmonary disease ?malignancy

Design outcomes

Primary

Measure	Time frame
The endpoint is circadian variation of serum uric acid and XOR, and oxidative stress marker	—

Countries

Japan

Contacts

Public ContactRyo Naito

Juntendo University School of Medicine, Juntendo Hospital Department of Cardiovascular Medicine

rnaitou@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026